Sachs G S
Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
J Clin Psychiatry. 1989 Dec;50 Suppl:31-9; discussion 45-7.
Lithium is the treatment of choice for bipolar affective disorder. In a substantial proportion of patients, however, the response to lithium is inadequate, thus necessitating the use of additional or alternative medications. The increasing awareness of drawbacks associated with the agents most frequently employed--heterocyclic antidepressants and neuroleptics--lends support to the clinical necessity for identification of alternatives to or enhancement of lithium therapy. Over the past 10 years several treatments have been reported to be effective for at least some cases of bipolar affective disorder. This article reviews the rationale for such therapies and the data supporting the use of some of the more promising agents. Emphasis is given to three classes of treatment: anticonvulsants, thyroid hormone augmentation, and serotonergic agents.
锂盐是双相情感障碍的首选治疗药物。然而,相当一部分患者对锂盐治疗反应欠佳,因此需要使用其他药物或替代药物。人们越来越意识到最常用药物——杂环类抗抑郁药和抗精神病药——存在的缺点,这支持了寻找锂盐治疗替代方案或增强其疗效的临床必要性。在过去10年里,有报道称几种治疗方法对至少部分双相情感障碍病例有效。本文回顾了这些治疗方法的理论依据以及支持使用一些更有前景药物的数据。重点介绍了三类治疗方法:抗惊厥药、甲状腺激素增强疗法和5-羟色胺能药物。